Patrick Walsh

Patrick Walsh

Amministratore Delegato presso
North Carolina Pharmaceutical Services LLC

Patrimonio netto: 3 M $ in data 31/05/2026

65 anni
Health Technology
Health Services
Commercial Services

Profilo

Patrick D.
Walsh
is the founder of Diligence Team LLC, founded in 2014, serving as President & Managing Member.
Mr. Walsh was the founder of TriPharm Services, Inc., founded in 2019, serving as Chief Executive Officer & Director from 2019 to 2020.
Mr. Walsh is the founder of Diligence Group LLC, founded in 2014, serving as Chairman.
Current jobs include Chief Executive Officer at North Carolina Pharmaceutical Services LLC; Chairman & Chief Executive Officer at Alcami Corp., Inc.; Executive Chairman at MedPharm Ltd. since 2024; Chairman at Alcami Corp.
since 2021; Member at the University of California, Irvine; and Operating Partner at Ampersand Management LLC since 2018.
Former jobs include Chief Executive Officer at Kadmus Pharmaceuticals, Inc. from 2003 to 2008; Chief Executive Officer at LPL Technologies, Inc. from 1998 to 2009; Chief Executive Officer at Alcami Carolinas Corp.
from 2010 to 2014; Chief Executive Officer at Accuratus Lab Services, Inc.; Chief Executive Officer & Director at Avista Pharma Solutions, Inc. from 2015 to 2019; Director at Lifecore Biomedical, Inc. from 2020 to 2021; Director at Microbix Biosystems, Inc.; Director at Brammer Biopharmaceuticals LLC; Director at ANI Pharmaceuticals, Inc. from 2025 to 2026; Independent Director at Avid Bioservices, Inc. from 2017 to 2021; Independent Non-Executive Director at ICE SpA from 2019 to 2024; Principal at Fujisawa Pharmaceutical Co., Ltd.; President & Chief Operating Officer at Gensia Sicor Pharmaceuticals, Inc. from 1994 to 1999; and President & Chief Operating Officer at SICOR, Inc. from 1994 to 1999.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
13/05/2026 38.432 ( 0,17% ) 3 M $ 31/05/2026

Posizioni attive di Patrick Walsh

SocietàPosizioneInizio
Corporate Officer/Principal -
Amministratore Delegato -
Diligence Team LLC
Fondatore 01/08/2014
Presidente 01/02/2024
Fondatore 01/08/2014
Investitore di Private Equity 01/03/2018
Amministratore Delegato -
Presidente 01/03/2021

Precedenti posizioni note di Patrick Walsh

SocietàPosizioneFine
ANI PHARMACEUTICALS, INC. Amministratore Delegato -
░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Patrick Walsh

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

62

Relazioni di 1° grado

24

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private24

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Finance

Consumer Services

Health Technology

Health Services

Commercial Services

Health Technology

Gensia Sicor Pharmaceuticals, Inc.

Health Services

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Commercial Services

Diligence Team LLC

Health Technology

Commercial Services

  1. Mercati
  2. Insiders
  3. Patrick Walsh
-40%: Proroga eccezionale
g
:
:
ENTRA ORA